Penserra Capital Management LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 167 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$3,694
-99.9%
64,291
-64.0%
0.07%
-52.3%
Q1 2022$6,418,000
+31990.0%
178,801
+16154.6%
0.15%
Q3 2021$20,000
-4.8%
1,100
+1.4%
0.00%
Q2 2021$21,000
+10.5%
1,085
+1.4%
0.00%
Q1 2021$19,000
-9.5%
1,070
-1.8%
0.00%
Q4 2020$21,000
+200.0%
1,090
+169.8%
0.00%
Q3 2020$7,0004040.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders